Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Love Pharma Inc ( (TSE:JOLT) ) has shared an announcement.
Jolt Health Inc. announced a consolidation of its common shares, approved by shareholders and its Board, to enhance flexibility for future financing opportunities. The consolidation will see a 20:1 share ratio change, reducing the number of shares and aligning warrants and options accordingly, pending Canadian Securities Exchange approval.
More about Love Pharma Inc
Jolt Health Inc. is a leading life sciences company focused on healthcare, biotechnology, and artificial intelligence. It holds exclusive licenses for innovative therapeutic and pharmaceutical products across Europe, the UK, and North America. The company is committed to transforming the healthcare industry through research, collaboration, and technological advancement.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$636.4K
See more data about JOLT stock on TipRanks’ Stock Analysis page.